IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MUSI, GENNARO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.249
AS - Asia 7.889
NA - Nord America 7.025
SA - Sud America 917
AF - Africa 242
OC - Oceania 65
Continente sconosciuto - Info sul continente non disponibili 6
Totale 29.393
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 7.362
US - Stati Uniti d'America 6.769
CN - Cina 2.789
SG - Singapore 2.737
IT - Italia 1.624
GB - Regno Unito 1.248
SE - Svezia 858
HK - Hong Kong 794
BR - Brasile 731
RU - Federazione Russa 558
IN - India 442
FR - Francia 355
NL - Olanda 273
IE - Irlanda 272
VN - Vietnam 266
FI - Finlandia 171
ID - Indonesia 151
CA - Canada 147
TR - Turchia 136
JP - Giappone 124
CI - Costa d'Avorio 120
KR - Corea 114
UA - Ucraina 88
DK - Danimarca 76
MX - Messico 66
AR - Argentina 62
ES - Italia 61
AT - Austria 58
AU - Australia 58
PH - Filippine 56
BD - Bangladesh 50
PL - Polonia 44
BE - Belgio 39
EC - Ecuador 38
ZA - Sudafrica 36
CH - Svizzera 35
IQ - Iraq 35
MA - Marocco 23
PE - Perù 22
EU - Europa 21
RO - Romania 21
CO - Colombia 20
EG - Egitto 19
IR - Iran 19
AE - Emirati Arabi Uniti 17
PK - Pakistan 16
SA - Arabia Saudita 16
NO - Norvegia 15
UZ - Uzbekistan 15
JO - Giordania 13
CZ - Repubblica Ceca 12
IL - Israele 12
VE - Venezuela 12
CL - Cile 11
GR - Grecia 11
TN - Tunisia 11
TW - Taiwan 11
EE - Estonia 10
AZ - Azerbaigian 9
NG - Nigeria 9
PT - Portogallo 9
AL - Albania 8
KE - Kenya 8
MY - Malesia 8
NP - Nepal 8
PY - Paraguay 8
HU - Ungheria 7
KZ - Kazakistan 7
LT - Lituania 7
TH - Thailandia 7
TT - Trinidad e Tobago 7
AM - Armenia 6
BO - Bolivia 6
CR - Costa Rica 6
JM - Giamaica 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
UY - Uruguay 6
ET - Etiopia 5
LB - Libano 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
CU - Cuba 3
HN - Honduras 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
MK - Macedonia 3
PA - Panama 3
BG - Bulgaria 2
BH - Bahrain 2
BY - Bielorussia 2
GE - Georgia 2
IS - Islanda 2
PS - Palestinian Territory 2
SC - Seychelles 2
SN - Senegal 2
Totale 29.383
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 6.857
Singapore 1.354
Ashburn 1.047
Southend 986
Chandler 676
Dallas 665
Hong Kong 659
Milan 546
Beijing 517
Hefei 359
Dublin 267
Princeton 244
Seattle 237
Council Bluffs 224
Fairfield 224
Los Angeles 202
Bengaluru 183
Santa Clara 179
San Jose 176
Wilmington 175
Buffalo 143
Ann Arbor 127
Houston 122
Jakarta 121
Abidjan 120
Rome 107
Cambridge 106
Munich 103
Guangzhou 100
New York 90
Des Moines 87
Woodbridge 87
Shanghai 86
Tokyo 84
Dearborn 82
Helsinki 81
Moscow 81
São Paulo 74
Columbus 73
Nanjing 73
Istanbul 69
Phoenix 68
Cangzhou 66
Berlin 64
Ho Chi Minh City 64
Hyderabad 55
Jinan 54
Montreal 49
Seoul 48
Toronto 48
Mountain View 47
Nuremberg 45
Boardman 44
Hanoi 44
The Dalles 42
Redmond 41
Tianjin 41
London 40
Changsha 38
Jacksonville 38
Brussels 36
Turin 35
Turku 34
Shenyang 33
Chicago 30
Hebei 29
Redwood City 29
Orem 27
Zhengzhou 27
Fuzhou 26
Silver Spring 26
Amsterdam 25
Dong Ket 25
Hangzhou 25
Vienna 25
Warsaw 23
Wuhan 23
Lappeenranta 22
Mumbai 22
Rio de Janeiro 22
San Diego 21
Florence 20
Serra 20
Brooklyn 19
Naples 19
Shenzhen 19
Belo Horizonte 18
Boston 18
Dhaka 18
Stockholm 18
Sydney 18
Chennai 17
Lima 17
Paris 17
Quanzhou 17
San Francisco 17
Chongqing 16
Johannesburg 16
Ningbo 16
Sakarya 16
Totale 19.630
Salva come PNG Salva come JPEG
Nome #
Anatomia del rabdomiosfintere uretrale da preparati anatomici autoptici 616
A novel nomogram to identify candidates for active surveillance among patients with ISUP Grade Group 1 or ISUP Grade Group 2 prostate cancer, according to multiparametric magnetic resonance imaging findings 426
Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer : a histology-validated study including 301 operated patients 366
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 355
Repeated MRIs during Active Surveillance: natural history of prostatic lesions and upgrading rates 299
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma 297
Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG 287
Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT) 283
Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy 281
Contemporary rates and predictors of open conversion during minimally invasive radical prostatectomy for non-metastatic prostate cancer 268
Scleroembolizzazione del plesso pampiniforme sec. Marmar modificato in età pediatrica 262
Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer 262
Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies 262
CyberKnife Ultra-Hypofractionated SBRT for Localized Prostate Cancer with Dose Escalation to the Dominant Intraprostatic Lesion: In Silico Planning Study 257
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml 255
High-performance prediction models for prostate cancer radiomics 249
Anterior prostatic tumours are difficult to diagnose without MRI 245
Multiparametric Magnetic Resonance Imaging Second Opinion May Reduce the Number of Unnecessary Prostate Biopsies : Time to Improve Radiologists’ Training Program? 240
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 238
Metabolic syndrome predicts worse perioperative outcomes in patients treated with partial nephrectomy for renal cell carcinoma 235
Robot assisted radical prostatectomy in kidney transplant recipients: surgical, oncological and functional outcomes of two different robotic approaches 227
Robot-assisted simple prostatectomy (RASP) : does it make sense? 224
Long-term follow‐up outcomes after percutaneous us/ct‐guided radiofrequency ablation for ct1a‐b renal masses : Experience from single high‐volume referral center 222
Robot-assisted radical prostatectomy : multiparametric MR imaging-directed intraoperative frozen-section analysis to reduce the rate of positive surgical margins 218
Correction: Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up (Prostate Cancer and Prostatic Diseases, (2020), 23, 1, (94-101), 10.1038/s41391-019-0160-3) 216
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 215
Bladder preservation in non-metastatic muscle-invasive bladder cancer (MIBC): a single-institution experience 212
A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor 210
Confirmatory multiparametric magnetic resonance imaging at recruitment confers prolonged stay in active surveillance and decreases the rate of upgrading at follow-up 210
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 203
Impact of surgical approach and resection technique on the risk of Trifecta Failure after partial nephrectomy for highly complex renal masses 202
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance 200
Penile-Sparing Surgery for Tumour Recurrence after Previous Glansectomy/Partial Penectomy: Treatment Feasibility and Oncological Outcomes 199
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 199
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 197
Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling 196
Robot-assisted intracorporeal orthotopic ileal neobladder : Description of the “shell” technique 195
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 194
A novel "intuitive" surgical technique for right robot-assisted retroperitoneal lymph node dissection for stage I testicular NSGCT 193
Neoadjuvant chemotherapy for invasive bladder cancer : an interesting case report 192
Quality of life and psycho-emotional wellbeing in bladder cancer patients and their caregivers: A comparative analysis between urostomy versus ileal orthotopic neobladder 192
Reporting combined outcomes with Trifecta and survival, continence, and potency (SCP) classification in 337 patients with prostate cancer treated with image-guided hypofractionated radiotherapy 191
Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients 191
Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol 191
Neoadjuvant chemotherapy for invasive bladder cancer : an interesting case report 190
A novel nomogram predicting lymph node invasion among patients with prostate cancer: The importance of extracapsular extension at multiparametric magnetic resonance imaging 190
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 190
Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation 189
Clinical evaluation and disease management of PI-RADS 3 lesions. Analysis from a single tertiary high-volume center 189
Robot-assisted Resection of a Wide-extending Abdominoperineal Angiomyofibroblastoma in a Male Patient 187
Beyond PSA : The role of prostate health index (phi) 187
Quality assurance for automatically generated contours with additional deep learning 185
Radiotherapy in prostate cancer patients with pelvic lymphocele after surgery: clinical and dosimetric data of 30 patients 184
Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score 183
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review 182
Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities 180
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 180
Adherence to EAU guidelines on penile cancer translates into better outcomes: a multicenter international study 178
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy 176
Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique : analysis of 542 consecutive patients 175
Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer : A Systematic Diagnostic Attempt 174
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy : a multicenter experience 174
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 174
Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer 173
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 173
Adherence to guideline recommendations for lymph node dissection in squamous cell carcinoma of the penis : effect on survival and complication rates 173
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience 173
Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy : preliminary report 172
Robot-Assisted Radical Cystectomy for Nonmetastatic Urothelial Carcinoma of Urinary Bladder: A Comparison between Intracorporeal Versus Extracorporeal Orthotopic Ileal Neobladder 172
Parametri prognostici nelle lesioni ecografiche impalpabili del testicolo 171
Postoperative vacuum therapy following AMS™ LGX 700® inflatable penile prosthesis placement: penile dimension outcomes and overall satisfaction 170
Thulium–yttrium–aluminium–garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of life 169
Robot-Assisted, Laparoscopic, and Open Radical Cystectomy: Pre-Operative Data of 1400 Patients From The Italian Radical Cystectomy Registry 168
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma 165
Circulating preoperative testosterone level predicts unfavourable disease at radical prostatectomy in men with International Society of Urological Pathology Grade Group 1 prostate cancer diagnosed with systematic biopsies 165
The role of MRI in the management of a prostate cancer patient with bone and lymph nodes metastases: A case report 165
First Live-Experience Session with PET/CT Specimen Imager: A pilot analysis in Prostate Cancer and Neuroendocrine Tumor 163
Microchirurgia conservativa delle lesioni testicolari benigne 163
Virtue male sling for post-prostatectomy stress incontinence : a prospective evaluation and mid-term outcomes 162
MRI-targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: follow-up of a PRECISION trial-like retrospective cohort 162
Comparison Between Micro-Ultrasound and Multiparametric MRI Regarding the Correct Identification of Prostate Cancer Lesions 162
Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement 160
Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy 155
Sexual function recovery after robot-assisted radical prostatectomy : outcomes from an Italian referral centre and predicting nomogram 153
Thermal ablation for small renal masses: Identifying the most appropriate tumor size cut-off for predicting perioperative and oncological outcomes 153
Comparison of Outcomes and Toxicity Between Extreme and Moderate Radiation Therapy Hypofractionation in Localized Prostate Cancer : A Propensity Score Analysis 152
Insertion of a testicular prosthesis at the time of radical orchiectomy for testicular cancer is safe in patients who will subsequently undergo chemotherapy or radiotherapy 152
Predictive clinico-pathological factors to identify BCG, unresponsive patients, after re-resection for T1 high grade non-muscle invasive bladder cancer 152
SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features 150
Impact of Perioperative Immunonutrition on Complications in Patients Undergoing Radical Cystectomy: A Retrospective Analysis 150
Impact of Age on Outcomes of Patients With Pure Carcinoma In Situ of the Bladder: Multi-Institutional Cohort Analysis 149
The impact of sars-cov-2 pandemic on time to primary, secondary resection and adjuvant intravesical therapy in patients with high-risk non-muscle invasive bladder cancer: A retrospective multi-institutional cohort analysis 149
What is the best time for postoperative radiation therapy in pN1 prostate cancer? 148
Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis 146
A guide for oncologic patient management during covid-19 pandemic: The initial experience of an Italian oncologic hub with exemplificative focus on uro-oncologic patients 146
Intraoperative radiotherapy for locally advanced prostate cancer : treatment technique and preliminary outcomes 145
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy 144
Three vs. Four Cycles of Neoadjuvant Chemotherapy for Localized Muscle Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Multi-Institutional Analysis 144
First case of bilateral intratubular germ cell tumor in androgen insensivity syndrome 143
Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer 142
Totale 20.193
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.771
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.771
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021888 0 0 0 0 0 0 169 87 256 129 138 109
2021/20221.807 83 90 72 96 200 161 79 114 174 148 138 452
2022/20232.720 333 292 202 214 220 424 186 206 347 44 194 58
2023/20246.429 101 135 129 148 466 267 1.022 890 446 829 983 1.013
2024/20257.582 937 897 808 709 429 355 265 515 307 492 572 1.296
2025/20267.241 1.371 1.222 1.470 1.132 1.045 745 256 0 0 0 0 0
Totale 30.322